Cargando…

miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells

It has been previously reported that the deregulation of microRNAs in gastric cancer (GC) was correlated with the progression and prognosis. miR-429, a member of the miR-200 family, was previously shown to play an important role in human carcinomas. Our study shows that miR-429 is significantly down...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Min, Dong, Bing-bin, Lu, Min, Zheng, Mei-juan, Chen, He, Ding, Jing-zhen, Xu, A-Man, Xu, Yuan-hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780435/
https://www.ncbi.nlm.nih.gov/pubmed/27042104
http://dx.doi.org/10.2147/OTT.S91879
Descripción
Sumario:It has been previously reported that the deregulation of microRNAs in gastric cancer (GC) was correlated with the progression and prognosis. miR-429, a member of the miR-200 family, was previously shown to play an important role in human carcinomas. Our study shows that miR-429 is significantly downregulated in GC tissues compared with matched nontumor tissues. Overexpression of miR-429 in GC cells suppressed cell proliferation. Fascin-1 (FSCN1) was identified as one of the targets of miR-429 and knockdown of FSCN1 mimics the function of miR-429 overexpression. In conclusion, miR-429 acts as a tumor suppressor by targeting FSCN1, suggesting that miR-429 and FSCN1 can both be potential therapeutic targets of GC.